Results 81 to 90 of about 3,493 (205)

The British Year Book of International Laiv I960

open access: yes, 1962
The British Year Book of International Laiv I960. In: Revue internationale de droit comparé. Vol. 14 N°2, Avril-juin 1962.

core   +1 more source

Immune responses after live attenuated influenza vaccination

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine (LAIV) has been used as an alternative to the traditional inactivated influenza vaccines (IIV).
Kristin G.-I. Mohn   +3 more
doaj   +1 more source

The safety of attenuated and recombinant nasal influenza vaccines in terms of the development of secondary bacterial superinfection

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2019
Introduction. Influenza is a severe viral disease. The most common post-influenza complication is pneumonia. Earlier, we developed an experimental mouse model of viralbacterial pneumonia induced by successive infection with influenza virus and St. aureus,
N. R. Makhmudova   +6 more
doaj   +1 more source

Seasonal Influenza Vaccination in People who Have Contact With Birds

open access: yesInfluenza and Other Respiratory Viruses, Volume 19, Issue 4, April 2025.
ABSTRACT Background Following the 2021–2022 avian influenza panzootic in birds and wildlife, seasonal influenza vaccines have been advised to occupationally high‐risk groups to reduce the likelihood of coincidental infection in humans with both seasonal and avian influenza A viruses.
Amy Thomas   +8 more
wiley   +1 more source

Valorización de Laive S.A.

open access: yes, 2018
El presente trabajo de investigación tiene por objetivo valorizar la empresa Laive S.A., estimando un valor por acción a diciembre de 2017. Laive tiene 108 años participando en el sector lácteo peruano, con una participación en el mercado del 9%.
Cabrera Chinchayán, Karina Aidé   +2 more
openaire   +1 more source

LAIV effect on cell populations in the peripheral blood (regardless of treatment).

open access: yes, 2016
LAIV effect on cell populations in the peripheral blood (regardless of treatment).
Ilona Jaspers (327122)   +8 more
core   +1 more source

Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)

open access: yesInfluenza and Other Respiratory Viruses, Volume 19, Issue 3, March 2025.
ABSTRACT Four significant influenza outbreaks have occurred over the past 100 years, and the 1918 influenza pandemic is the most severe. Since influenza viruses undergo antigenic evolution, they are the pathogens most likely to trigger a new pandemic shortly.
Sara Yahyaei   +6 more
wiley   +1 more source

Valorización de Laive S.A.

open access: yes, 2017
El objetivo del presente trabajo es valorizar la empresa Laive a diciembre de 2016, para lo cual utilizamos dos métodos, el método del flujo de caja descontado y el de los múltiplos. En el primer método consideramos un valor del WACC de 8,82% y un valor CAPM 10,56%, con lo cual arrojó un valor de S/ 1,85 para la acción B de Laive, cifra superior en 51 ...
Rojas Bazan, Angel Nino   +1 more
openaire   +1 more source

LAIV-specific adverse events. 3,707 TIV-induced AE cases were reported.

open access: yes, 2012
LAIV-specific adverse events. 3,707 TIV-induced AE cases were reported.
Brian D. Athey (116831)   +6 more
core   +1 more source

Transcriptome analysis in human breast milk and blood in a randomized trial after inactivated or attenuated influenza immunization

open access: yesnpj Vaccines
Transcriptomic signatures were identified in human peripheral blood mononuclear cells (PBMCs) and breast milk lymphocyte (BML) cells induced by trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV) administered after ...
Elizabeth P. Schlaudecker   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy